聚合物囊泡
纳米载体
药理学
癌症免疫疗法
免疫系统
免疫疗法
外周血单个核细胞
医学
癌症研究
兴奋剂
全身给药
癌细胞
药物输送
效力
癌症
淋巴
树突状细胞
快速反应
免疫原性细胞死亡
受体
癌症治疗
药品
免疫学
毒品携带者
细胞因子
治疗效果
电穿孔
作者
Shaoqiong Liu,Ser Yue Loo,Jian Hang Lam,Wei Xiang Poh,Yan Jun Lee,Suet Li Chew,Melvin Liew,Salmah Humairoh Binte Zamri,Katherine Schultheis,George Griesgraber,Mark Tomai,Madhavan Nallani
摘要
]quinolin-4-amine hydrochloride (3M-060), a novel compound with superior immunostimulatory potency encapsulated in nanoscale size polymersomes (ACM-3M-060). ACM-3M-060 elicited stronger induction of pro-inflammatory cytokines than resiquimod (R848) loaded polymersomes (ACM-R848) in human peripheral blood mononuclear cells (PBMCs), while preserving the native activity of the free drug. In a murine CT26 tumor model, intratumoral administration of an ACM-3M-060 analogue labeled with rhodamine led to prolonged retention in the tumor, enhanced drug uptake in the tumor-draining lymph nodes (DLNs) and reduced systemic exposure. Notably, ACM-3M-060 achieved superior tumor growth inhibition compared to the free drug, with a proportion of mice achieving complete tumor regression. Rechallenge with CT26 cells in these animals failed to establish tumors, demonstrating durable antitumor immune memory. This therapeutic effect is primarily driven by TLR7/8-mediated immunomodulation and increased expression of markers of T-cell activity. These findings demonstrate that polymersome delivery enables the safe and effective local administration of potent TLR7/8 agonists such as 3M-060 for cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI